The role of maintenance therapy in multiple myeloma

B. Lipe, R. Vukas, J. Mikhael

Research output: Contribution to journalArticlepeer-review

17 Scopus citations


Multiple myeloma is the second most common type of blood cancer and remains incurable despite advances in therapy. Current therapy for multiple myeloma includes a phased-approach, often consisting of initial induction therapy, consolidation and maintenance therapy. With an ever-growing landscape of treatment options, the approach to optimal therapy has become increasingly complex. Specifically, controversy surrounds the optimal use and duration of maintenance therapy. We conducted a comprehensive literature search to analyze the most current literature and to provide recommendations for maintenance therapy in multiple myeloma.

Original languageEnglish (US)
Article numbere485
JournalBlood cancer journal
Issue number10
StatePublished - Oct 21 2016

ASJC Scopus subject areas

  • Hematology
  • Oncology


Dive into the research topics of 'The role of maintenance therapy in multiple myeloma'. Together they form a unique fingerprint.

Cite this